Proteome Sciences plc (PMSNF)
USD 0.03
(7.14%)
USD 0.03
(7.14%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.06 Million USD | -2.22% |
| 2022 | 1.08 Million USD | -25.91% |
| 2021 | 1.47 Million USD | 22.54% |
| 2020 | 1.2 Million USD | 4.01% |
| 2019 | 1.15 Million USD | -21.01% |
| 2018 | 1.46 Million GBP | 14.15% |
| 2017 | 1.27 Million GBP | 72.61% |
| 2016 | 741.38 Thousand GBP | 72.86% |
| 2015 | 428.9 Thousand GBP | 24.68% |
| 2014 | 344 Thousand GBP | -14.55% |
| 2013 | 402.58 Thousand GBP | 21.47% |
| 2012 | 331.43 Thousand GBP | 10.29% |
| 2011 | 300.52 Thousand GBP | 43.79% |
| 2010 | 209 Thousand GBP | 22.94% |
| 2009 | 170 Thousand GBP | -9.57% |
| 2008 | 188 Thousand GBP | 75.7% |
| 2007 | 107 Thousand GBP | 0.0% |
| 2006 | - GBP | 0.0% |
| 2005 | - GBP | 0.0% |
| 2004 | - GBP | 0.0% |
| 2003 | - GBP | 0.0% |
| 2002 | - GBP | 0.0% |
| 2001 | - GBP | 0.0% |
| 2000 | - GBP | 0.0% |
| 1999 | - GBP | 0.0% |
| 1998 | - GBP | 0.0% |
| 1997 | - GBP | 0.0% |
| 1996 | - GBP | 0.0% |
| 1995 | - GBP | 0.0% |
| 1994 | - GBP | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 976.03 Thousand USD | 0.0% |
| 2023 Q4 | 1.06 Million USD | 4.34% |
| 2023 Q3 | 1.02 Million GBP | -11.79% |
| 2023 Q1 | 1.12 Million GBP | 3.25% |
| 2023 FY | 1.06 Million USD | -2.22% |
| 2023 Q2 | 1.15 Million USD | 2.89% |
| 2022 Q3 | 1 Million GBP | -20.36% |
| 2022 Q2 | 1.26 Million GBP | -7.35% |
| 2022 Q4 | 1.08 Million USD | 8.3% |
| 2022 Q1 | 1.36 Million GBP | -7.29% |
| 2022 FY | 1.08 Million USD | -25.91% |
| 2021 Q3 | 1.46 Million GBP | 16.88% |
| 2021 Q1 | 1.25 Million GBP | 4.29% |
| 2021 FY | 1.47 Million USD | 22.54% |
| 2021 Q4 | 1.47 Million GBP | 0.32% |
| 2021 Q2 | 1.25 Million GBP | 0.21% |
| 2020 Q3 | 1.13 Million GBP | -4.19% |
| 2020 Q1 | 1.18 Million GBP | 3.12% |
| 2020 Q2 | 1.18 Million GBP | -0.62% |
| 2020 Q4 | 1.2 Million GBP | 5.94% |
| 2020 FY | 1.2 Million USD | 4.01% |
| 2019 Q2 | 1.28 Million GBP | -2.28% |
| 2019 FY | 1.15 Million USD | -21.01% |
| 2019 Q1 | 1.31 Million GBP | 14.91% |
| 2019 Q4 | 1.15 Million GBP | 7.74% |
| 2019 Q3 | 1.07 Million GBP | -16.85% |
| 2018 FY | 1.46 Million GBP | 14.15% |
| 2018 Q2 | 789 Thousand GBP | -28.73% |
| 2018 Q1 | 1.1 Million GBP | 17.02% |
| 2018 Q3 | 1.49 Million GBP | 89.46% |
| 2018 Q4 | 1.14 Million GBP | -23.27% |
| 2017 Q4 | 946 Thousand GBP | -25.36% |
| 2017 Q3 | 1.26 Million GBP | 127.96% |
| 2017 Q2 | 556 Thousand GBP | -20.19% |
| 2017 FY | 1.27 Million GBP | 72.61% |
| 2017 Q1 | 696.65 Thousand GBP | 16.11% |
| 2016 Q1 | 524.26 Thousand GBP | 80.16% |
| 2016 Q4 | 600 Thousand GBP | -22.86% |
| 2016 Q2 | 364 Thousand GBP | -30.57% |
| 2016 FY | 741.38 Thousand GBP | 72.86% |
| 2016 Q3 | 777.81 Thousand GBP | 113.68% |
| 2015 Q4 | 291 Thousand GBP | -33.91% |
| 2015 Q1 | 444.39 Thousand GBP | 29.18% |
| 2015 FY | 428.9 Thousand GBP | 24.68% |
| 2015 Q3 | 440.34 Thousand GBP | 47.21% |
| 2015 Q2 | 299.12 Thousand GBP | -32.69% |
| 2014 Q3 | 558.03 Thousand GBP | 43.64% |
| 2014 FY | 344 Thousand GBP | -14.55% |
| 2014 Q2 | 388.49 Thousand GBP | -40.0% |
| 2014 Q1 | 647.54 Thousand GBP | 60.85% |
| 2014 Q4 | 344 Thousand GBP | -38.35% |
| 2013 FY | 402.58 Thousand GBP | 21.47% |
| 2013 Q2 | 367.69 Thousand GBP | -34.14% |
| 2013 Q1 | 558.34 Thousand GBP | 68.46% |
| 2013 Q4 | 402.58 Thousand GBP | -38.23% |
| 2013 Q3 | 651.79 Thousand GBP | 77.26% |
| 2012 Q4 | 331.43 Thousand GBP | 0.0% |
| 2012 FY | 331.43 Thousand GBP | 10.29% |
| 2012 Q2 | 480 Thousand GBP | 0.0% |
| 2011 FY | 300.52 Thousand GBP | 43.79% |
| 2011 Q4 | 300.52 Thousand GBP | 0.0% |
| 2011 Q2 | 251 Thousand GBP | 0.0% |
| 2010 Q4 | 209 Thousand GBP | 0.0% |
| 2010 Q2 | 220 Thousand GBP | 0.0% |
| 2010 FY | 209 Thousand GBP | 22.94% |
| 2009 Q2 | 172 Thousand GBP | 0.0% |
| 2009 FY | 170 Thousand GBP | -9.57% |
| 2009 Q4 | 170 Thousand GBP | 0.0% |
| 2008 FY | 188 Thousand GBP | 75.7% |
| 2008 Q4 | 188 Thousand GBP | 0.0% |
| 2008 Q2 | 191 Thousand GBP | 0.0% |
| 2007 Q2 | - GBP | 0.0% |
| 2007 FY | 107 Thousand GBP | 0.0% |
| 2007 Q4 | 107 Thousand GBP | 0.0% |
| 2006 Q4 | - GBP | 0.0% |
| 2006 Q2 | - GBP | 0.0% |
| 2006 FY | - GBP | 0.0% |
| 2005 Q2 | - GBP | 0.0% |
| 2005 Q4 | - GBP | 0.0% |
| 2005 FY | - GBP | 0.0% |
| 2004 Q2 | - GBP | 0.0% |
| 2004 Q4 | - GBP | 0.0% |
| 2004 FY | - GBP | 0.0% |
| 2003 FY | - GBP | 0.0% |
| 2002 FY | - GBP | 0.0% |
| 2001 FY | - GBP | 0.0% |
| 2000 FY | - GBP | 0.0% |
| 1999 FY | - GBP | 0.0% |
| 1998 FY | - GBP | 0.0% |
| 1997 FY | - GBP | 0.0% |
| 1996 FY | - GBP | 0.0% |
| 1995 FY | - GBP | 0.0% |
| 1994 FY | - GBP | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Bio Medica Corporation | 379 Thousand USD | -181.135% |
| Arrayit Corporation | 464.19 Thousand USD | -129.539% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 757 Thousand USD | -40.753% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | -2385.00 USD | 44775.094% |
| DermTech, Inc. | 1 Million USD | -6.126% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 67.703% |
| HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | -17.175% |
| iMD Companies, Inc. | 38.31 Thousand USD | -2680.825% |
| IDenta Corp. | 442.28 Thousand USD | -140.91% |
| Interpace Biosciences, Inc. | 1.22 Million USD | 13.162% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 163.13 Thousand USD | -553.141% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | -35.906% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 284233.6% |
| Medical Imaging Corp. | - USD | -Infinity% |
| NovelStem International Corp. | - USD | -Infinity% |
| Optigenex Inc. | 468.77 Thousand USD | -127.295% |
| PharmChem, Inc. | 391.93 Thousand USD | -171.855% |
| Response Genetics, Inc | 133 Thousand USD | -701.129% |
| Rennova Health, Inc. | 242.64 Thousand USD | -339.119% |
| RushNet, Inc. | - USD | -Infinity% |
| ScreenPro Security Inc. | 73.89 Thousand USD | -1341.873% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | -1014.296% |
| Todos Medical Ltd. | 1.02 Million USD | -4.359% |